Omic
Omic is a pioneering AI-driven platform specializing in multi-omic biomedical discoveries to revolutionize drug discovery and therapy design. Their platform integrates hundreds of advanced machine learning models, bioinformatics pipelines, and one of the world's largest biomedical knowledge graphs to reverse engineer diseases, generate novel biologics and small molecules, and test therapies on realistic digital patient cohorts. Omic's technology enables the identification of novel drug targets, creation of complex immunotherapies, and in silico testing to optimize treatment efficacy and safety, accelerating preclinical R&D and improving personalized medicine. The company is led by founder Gabe Richman, leveraging expertise in genetics, engineering, and SaaS leadership, positioning Omic as a leader in AI-powered systems biology for therapeutic innovation.
Omic
Omic is a pioneering AI-driven platform specializing in multi-omic biomedical discoveries to revolutionize drug discovery and therapy design. Their platform integrates hundreds of advanced machine learning models, bioinformatics pipelines, and one of the world's largest biomedical knowledge graphs to reverse engineer diseases, generate novel biologics and small molecules, and test therapies on realistic digital patient cohorts. Omic's technology enables the identification of novel drug targets, creation of complex immunotherapies, and in silico testing to optimize treatment efficacy and safety, accelerating preclinical R&D and improving personalized medicine. The company is led by founder Gabe Richman, leveraging expertise in genetics, engineering, and SaaS leadership, positioning Omic as a leader in AI-powered systems biology for therapeutic innovation.